10-K Filing

YUBO INTERNATIONAL BIOTECH LTD CIK: 895464 FY 2019

Filing Information

Form Type	10-K
Accession Number	`0001193805-20-000741`
Period End Date	20200229
Filing Date	20200625
Fiscal Year	2019
Fiscal Period	FY
XBRL Instance	magaa-20200229.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 33 Income Statement 18 Cash Flow Statement 20 Stockholders Equity 8

Balance Sheet 33 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash	`Cash`	$1.00K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash	`Cash`	$4.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$4.00K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Total assets	`Assets`	$4.00K	USD	Point-in-time
Total assets	`Assets`	$1.00K	USD	Point-in-time
Notes payable and accrued interest payable to related parties	`NotesPayableRelatedPartiesClassifiedCurrent`	$1.41M	USD	Point-in-time
Notes payable and accrued interest payable to related parties	`NotesPayableRelatedPartiesClassifiedCurrent`	$1.28M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$353.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$342.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$40.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$41.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.80M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.67M	USD	Point-in-time
COMMITMENTS AND CONTINGENCIES (Notes 4, 7 and 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENTS AND CONTINGENCIES (Notes 4, 7 and 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $.01 per share, 5,000,000 shares authorized, none issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $.01 per share, 5,000,000 shares authorized, none issued	`PreferredStockValue`	-	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$27.29M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$27.29M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-29.09M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-28.95M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-1.66M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-1.80M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-1.52M	USD	Point-in-time
Total liabilities and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$4.00K	USD	Point-in-time
Total liabilities and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$1.00K	USD	Point-in-time

Income Statement 18 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	-	USD	Annual
Revenues	`Revenues`	-	USD	Annual
General and administrative	`SellingGeneralAndAdministrativeExpense`	$48.00K	USD	Annual
General and administrative	`SellingGeneralAndAdministrativeExpense`	$29.00K	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-48.00K	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-29.00K	USD	Annual
Interest expense	`InterestExpense`	$105.00K	USD	Annual
Interest expense	`InterestExpense`	$100.00K	USD	Annual
Net loss before income tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$-148.00K	USD	Annual
Net loss before income tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$-134.00K	USD	Annual
Provision fro income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Provision fro income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Net loss	`NetIncomeLoss`	$-134.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-148.00K	USD	Annual
Weighted average number of common shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.18M	shares	Annual
Weighted average number of common shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.18M	shares	Annual
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.11	USD	Annual
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.13	USD	Annual

Cash Flow Statement 20 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-134.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-148.00K	USD	Annual
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$112.00K	USD	Annual
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$116.00K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-22.00K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-32.00K	USD	Annual
Proceeds received from notes payable to shareholder	`ProceedsFromRelatedPartyDebt`	$19.00K	USD	Annual
Proceeds received from notes payable to shareholder	`ProceedsFromRelatedPartyDebt`	$34.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$34.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$19.00K	USD	Annual
Net cash provided by or used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	Annual
Net cash provided by or used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	Annual
Net (decrease) increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-3.00K	USD	Annual
Net (decrease) increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$2.00K	USD	Annual
Beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$4.00K	USD	Point-in-time
Beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$2.00K	USD	Point-in-time
Beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$1.00K	USD	Point-in-time
End of year	`CashAndCashEquivalentsAtCarryingValue`	$4.00K	USD	Point-in-time
End of year	`CashAndCashEquivalentsAtCarryingValue`	$2.00K	USD	Point-in-time
End of year	`CashAndCashEquivalentsAtCarryingValue`	$1.00K	USD	Point-in-time

Stockholders Equity 8 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$-1.66M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$-1.80M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$-1.52M	USD	Point-in-time
Net loss	`NetIncomeLoss`	$-134.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-148.00K	USD	Annual
Ending balance, value	`StockholdersEquity`	$-1.66M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$-1.80M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$-1.52M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.